{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:26:22Z","timestamp":1789986382602,"version":"4.0.1"},"reference-count":64,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2018,5,12]],"date-time":"2018-05-12T00:00:00Z","timestamp":1526083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000320","name":"Alzheimer's Society","doi-asserted-by":"publisher","award":["317, AS-SF-16-003"],"award-info":[{"award-number":["317, AS-SF-16-003"]}],"id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Molecular chaperones are key components of the protein homeostasis system against protein misfolding and aggregation. It has been recently shown that these molecules can be rationally modified to have an enhanced activity against specific amyloidogenic substrates. The resulting molecular chaperone variants can be effective inhibitors of protein aggregation in vitro, thus suggesting that they may provide novel opportunities in biomedical and biotechnological applications. Before such opportunities can be exploited, however, their effects on cell viability should be better characterised. Here, we employ a rational design method to specifically enhance the activity of the 70-kDa heat shock protein (Hsp70) against the aggregation of the human islet amyloid polypeptide (hIAPP, also known as amylin). We then show that the Hsp70 variant that we designed (grafted heat shock protein 70 kDa-human islet amyloid polypeptide, GHsp70-hIAPP) is significantly more effective than the wild type in recovering the viability of cultured pancreatic islet \u03b2-cells RIN-m5F upon hIAPP aggregation. These results indicate that a full recovery of the toxic effects of hIAPP aggregates on cultured pancreatic cells can be achieved by increasing the specificity and activity of Hsp70 towards hIAPP, thus providing evidence that the strategy presented here provides a possible route for rationally tailoring molecular chaperones for enhancing their effects in a target-dependent manner.<\/jats:p>","DOI":"10.3390\/ijms19051443","type":"journal-article","created":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T02:57:20Z","timestamp":1526266640000},"page":"1443","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["A Rationally Designed Hsp70 Variant Rescues the Aggregation-Associated Toxicity of Human IAPP in Cultured Pancreatic Islet \u03b2-Cells"],"prefix":"10.3390","volume":"19","author":[{"given":"Marie Nicole","family":"Bongiovanni","sequence":"first","affiliation":[{"name":"Centre for Misfolding Diseases, Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5040-4420","authenticated-orcid":false,"given":"Francesco Antonio","family":"Aprile","sequence":"additional","affiliation":[{"name":"Centre for Misfolding Diseases, Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Sormanni","sequence":"additional","affiliation":[{"name":"Centre for Misfolding Diseases, Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3616-1610","authenticated-orcid":false,"given":"Michele","family":"Vendruscolo","sequence":"additional","affiliation":[{"name":"Centre for Misfolding Diseases, Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,5,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/381571a0","article-title":"Molecular chaperones in cellular protein folding","volume":"381","author":"Hartl","year":"1996","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cell.2006.04.014","article-title":"Molecular Chaperones and Protein Quality Control","volume":"125","author":"Bukau","year":"2006","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1126\/science.1141448","article-title":"Adapting Proteostasis for Disease Intervention","volume":"319","author":"Balch","year":"2008","journal-title":"Science"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"a004507","DOI":"10.1101\/cshperspect.a004507","article-title":"Chemical and Biological Approaches for Adapting Proteostasis to Ameliorate Protein Misfolding and Aggregation Diseases\u2013Progress and Prognosis","volume":"3","author":"Lindquist","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature10317","article-title":"Molecular chaperones in protein folding and proteostasis","volume":"475","author":"Hartl","year":"2011","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.celrep.2014.09.042","article-title":"A Chaperome Subnetwork Safeguards Proteostasis in Aging and Neurodegenerative Disease","volume":"9","author":"Brehme","year":"2014","journal-title":"Cell Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"10948","DOI":"10.1038\/ncomms10948","article-title":"Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation","volume":"7","author":"Arosio","year":"2016","journal-title":"Nat. Comm."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"aac4354","DOI":"10.1126\/science.aac4354","article-title":"In vivo aspects of protein folding and quality control","volume":"353","author":"Balchin","year":"2016","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1126\/science.1101262","article-title":"Harnessing chaperones to generate small-molecule inhibitors of amyloid \u03b2 aggregation","volume":"306","author":"Gestwicki","year":"2004","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrn1587","article-title":"Modulation of neurodegeneration by molecular chaperones","volume":"6","author":"Muchowski","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S1474-4422(16)00099-5","article-title":"Heat shock proteins as potential targets for protective strategies in neurodegeneration","volume":"15","author":"Kampinga","year":"2016","journal-title":"Lancet Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev-pharmtox-010814-124332","article-title":"Targeting Hsp90\/Hsp70-based protein quality control for treatment of adult onset neurodegenerative diseases","volume":"55","author":"Pratt","year":"2015","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gde.2017.01.008","article-title":"Designer protein disaggregases to counter neurodegenerative disease","volume":"44","author":"Shorter","year":"2017","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/nature02261","article-title":"Protein folding and misfolding","volume":"426","author":"Dobson","year":"2003","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.tcb.2014.05.003","article-title":"Proteostasis impairment in protein-misfolding and -aggregation diseases","volume":"24","author":"Hipp","year":"2014","journal-title":"Trends Cell Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nrd3050","article-title":"Protein aggregation diseases: Pathogenicity and therapeutic perspectives","volume":"9","author":"Aguzzi","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer\u2019s amyloid \u03b2-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrm3810","article-title":"The amyloid state and its association with protein misfolding diseases","volume":"15","author":"Knowles","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrm2993","article-title":"Cellular strategies for controlling protein aggregation","volume":"11","author":"Tyedmers","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","article-title":"Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders","volume":"26","author":"Caughey","year":"2003","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.cell.2012.02.022","article-title":"The amyloid state of proteins in human diseases","volume":"148","author":"Eisenberg","year":"2012","journal-title":"Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer\u2019s disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"14733","DOI":"10.1074\/jbc.M413024200","article-title":"Heat Shock Protein 70 Inhibits \u03b1-Synuclein Fibril Formation via Preferential Binding to Prefibrillar Species","volume":"280","author":"Dedmon","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"33182","DOI":"10.1074\/jbc.M606192200","article-title":"Heat Shock Proteins 70 and 90 Inhibit Early Stages of Amyloid \u03b2-(1\u201342) Aggregation in Vitro","volume":"281","author":"Evans","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jmb.2007.02.095","article-title":"The Extracellular Chaperone Clusterin Potently Inhibits Human Lysozyme Amyloid Formation by Interacting with Prefibrillar Species","volume":"369","author":"Kumita","year":"2007","journal-title":"J. Mol. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1038\/emboj.2009.298","article-title":"Chaperone proteostasis in Parkinson\u2019s disease: Stabilization of the Hsp70\/\u03b1-synuclein complex by Hip","volume":"28","author":"Roodveldt","year":"2009","journal-title":"EMBO J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12035-010-8116-6","article-title":"Multifaceted Role of Heat Shock Protein 70 in Neurons","volume":"42","author":"Lu","year":"2010","journal-title":"Mol. Neurobiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s00018-004-4464-6","article-title":"Hsp70 chaperones: Cellular functions and molecular mechanism","volume":"62","author":"Mayer","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1126\/science.1067389","article-title":"Chaperone Suppression of \u03b1-Synuclein Toxicity in a Drosophila Model for Parkinson\u2019s Disease","volume":"295","author":"Auluck","year":"2002","journal-title":"Science"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/hmg\/10.14.1511","article-title":"Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice","volume":"10","author":"Cummings","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"25497","DOI":"10.1074\/jbc.M400255200","article-title":"Hsp70 Reduces \u03b1-Synuclein Aggregation and Toxicity","volume":"279","author":"Klucken","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1101\/gad.1188204","article-title":"Hsp70 promotes TNF-mediated apoptosis by binding IKK\u03b3 and impairing NF-\u03baB survival signaling","volume":"18","author":"Ran","year":"2004","journal-title":"Genes Dev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0958-1669(96)80012-7","article-title":"Expression of correctly folded proteins in Escherichia coli","volume":"7","author":"Georgiou","year":"1996","journal-title":"Curr. Opin. Biotech."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/2051-5960-1-79","article-title":"Molecular chaperones and protein folding as therapeutic targets in Parkinson\u2019s disease and other synucleinopathies","volume":"1","author":"Saidi","year":"2013","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_36","first-page":"43","article-title":"Hsp70 ATPase Modulators as Therapeutics for Alzheimer\u2019s and other Neurodegenerative Diseases","volume":"2","author":"Jinwal","year":"2010","journal-title":"Mol. Cell. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/1756285613493469","article-title":"Targeting heat shock proteins to modulate \u03b1-synuclein toxicity","volume":"7","author":"Jones","year":"2014","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2174\/187152710793237386","article-title":"Molecular chaperones as rational drug targets for Parkinson\u2019s disease therapeutics","volume":"9","author":"Kalia","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1006\/jmbi.1998.2514","article-title":"Mutations in the substrate binding domain of the Escherichia coli 70 kda molecular chaperone, DnaK, which alter substrate affinity or interdomain coupling1","volume":"286","author":"Montgomery","year":"1999","journal-title":"J. Mol. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molcel.2005.12.017","article-title":"Allosteric Regulation of Hsp70 Chaperones by a Proline Switch","volume":"21","author":"Vogel","year":"2006","journal-title":"Mol. Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1749-6632.2000.tb05605.x","article-title":"Heat Shock Protein 70 Is Required for the Survival of Cancer Cells","volume":"926","author":"Nylandsted","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1038\/onc.2014.349","article-title":"Hsp70 in cancer: Back to the future","volume":"34","author":"Sherman","year":"2015","journal-title":"Oncogene"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc1716","article-title":"HSP90 and the chaperoning of cancer","volume":"5","author":"Whitesell","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1021\/acs.biochem.5b00459","article-title":"A Rational Design Strategy for the Selective Activity Enhancement of a Molecular Chaperone toward a Target Substrate","volume":"54","author":"Aprile","year":"2015","journal-title":"Biochemistry"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","article-title":"Islet amyloid polypeptide: Pinpointing amino acid residues linked to amyloid fibril formation","volume":"87","author":"Westermark","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/368756a0","article-title":"Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus","volume":"368","author":"Lorenzo","year":"1994","journal-title":"Nature"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1073\/pnas.0708354105","article-title":"Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane","volume":"105","author":"Engel","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Lopez, L.C., Varea, O., Navarro, S., Carrodeguas, J.A., Sanchez de Groot, N., Ventura, S., and Sancho, J. (2016). Benzbromarone, Quercetin, and Folic Acid Inhibit Amylin Aggregation. Intl. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17060964"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1002\/anie.200705372","article-title":"Small-Molecule Inhibitors of Islet Amyloid Polypeptide Fibril Formation","volume":"47","author":"Mishra","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1021\/bi100939a","article-title":"The flavanol (\u2212)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity","volume":"49","author":"Meng","year":"2010","journal-title":"Biochemistry"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/BJ20100434","article-title":"The chaperone proteins HSP70, HSP40\/DnaJ and GRP78\/BiP suppress misfolding and formation of \u03b2-sheet-containing aggregates by human amylin: A potential role for defective chaperone biology in Type 2 diabetes","volume":"432","author":"Chien","year":"2010","journal-title":"Biochem. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.4049\/jimmunol.180.6.4299","article-title":"Hsp70 Translocates into the Plasma Membrane after Stress and Is Released into the Extracellular Environment in a Membrane-Associated Form that Activates Macrophages","volume":"180","author":"Vega","year":"2008","journal-title":"J. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0014-5793(99)00894-7","article-title":"Induction of apoptosis by human amylin in RINm5F islet \u03b2-cells is associated with enhanced expression of p53 and p21WAF1\/CIP1","volume":"455","author":"Zhang","year":"1999","journal-title":"FEBS Lett."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"36086","DOI":"10.1074\/jbc.M111.240762","article-title":"Clustering and Internalization of Toxic Amylin Oligomers in Pancreatic Cells Require Plasma Membrane Cholesterol","volume":"286","author":"Trikha","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Trikha, S., and Jeremic, A.M. (2013). Distinct internalization pathways of human amylin monomers and its cytotoxic oligomers in pancreatic cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0073080"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"9902","DOI":"10.1073\/pnas.1422401112","article-title":"Rational design of antibodies targeting specific epitopes within intrinsically disordered proteins","volume":"112","author":"Sormanni","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Pillay, K., Govender, P., Pillay, K., and Govender, P. (2013). Amylin Uncovered: A Review on the Polypeptide Responsible for Type II Diabetes. BioMed. Res. Int., e826706.","DOI":"10.1155\/2013\/826706"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0167-4889(89)90220-6","article-title":"Amylin and the amylin gene: Structure, function and relationship to islet amyloid and to diabetes mellitus","volume":"1014","author":"Cooper","year":"1989","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1006\/cbir.2000.0643","article-title":"Ultrastructural evidence that apoptosis is the mechanism by which human amylin evokes death in RINm5F pancreatic islet \u03b2-cells","volume":"25","author":"Saafi","year":"2001","journal-title":"Cell Biol. Int."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/jmbi.1998.2299","article-title":"Watching amyloid fibrils grow by time-lapse atomic force microscopy1","volume":"285","author":"Goldsbury","year":"1999","journal-title":"J. Mol. Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1006\/jsbi.2000.4268","article-title":"Amyloid Fibril Formation from Full-Length and Fragments of Amylin","volume":"130","author":"Goldsbury","year":"2000","journal-title":"J. Struct. Biol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"E1317","DOI":"10.1152\/ajpendo.00082.2006","article-title":"Inhibition of human IAPP fibril formation does not prevent \u03b2 -cell death: Evidence for distinct actions of oligomers and fibrils of human IAPP","volume":"291","author":"Meier","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. MeTable"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1096\/fj.11-194613","article-title":"Concentration-dependent transitions govern the subcellular localization of islet amyloid polypeptide","volume":"26","author":"Magzoub","year":"2012","journal-title":"FASEB J."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/5\/1443\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:03:58Z","timestamp":1760195038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/5\/1443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,12]]},"references-count":64,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5]]}},"alternative-id":["ijms19051443"],"URL":"https:\/\/doi.org\/10.3390\/ijms19051443","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,12]]}}}